Jeffrey Shapiro, MD
Orthopaedic Surgery · Southfield, MINPI 1235111204
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $231,007 of the $233,437 with a category attached, or 99.0%. Arthrex accounts for 99.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $95,353 and has fallen 99.8% since, to $184 in 2025. Among orthopaedic surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $8978.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$232K
- Pinnacle, Inc$920
- Bioventus LLC$81
- Curonix LLC$45
- Nalu Medical, Inc.$35
- Nevro Corp.$32
- plus $69 from 3 others
What the payments were for
- Royalty or licence$231,00799%
- Travel & lodging$2360%
- Food & beverage$4410%
- Education$1,7531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 11 | $232,255 |
| Pinnacle, Inc | 5 | $920 |
| Bioventus LLC | 3 | $81 |
| Curonix LLC | 2 | $45 |
| Nalu Medical, Inc. | 1 | $35 |
| Nevro Corp. | 1 | $32 |
| Abbott | 1 | $31 |
| Boston Scientific | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$233,437 in reported general payments places this provider in the 95th percentile of 829 orthopaedic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 64 | $1,152 |
| Meloxicam | 272 | $686 |
| Cephalexin | 91 | $421 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $394 |
| Tramadol Hcl | 89 | $200 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $133 |
| Cefadroxil | 21 | $125 |
| Methylprednisolone | 20 | $109 |
| Oxycodone Hcl | 20 | $70 |
| Gabapentin | 15 | $49 |
| Ondansetron Hcl | 19 | $45 |
| Dexamethasone | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Southfield
- Jad KhalilSouthfield$1.9M
- Jeffrey FischgrundSouthfield$1.8M
- David MarkelSouthfield$1.5M
- Jefferey MichaelsonSouthfield$300K
- David KnesekSouthfield$189K
- Asheesh BediAnn Arbor$9.4M
- Jerome WiaterBeverly Hills$3.9M
- Mark PintoChelsea$3.2M
- Kyle AndersonBingham Farms$3.1M
- Stephen BartolDetroit$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.